Thalidomide and dexamethasone: a new standard of care for initial therapy in multiple myeloma
- PMID: 16365174
- DOI: 10.1200/JCO.2005.03.8851
Thalidomide and dexamethasone: a new standard of care for initial therapy in multiple myeloma
Comment in
-
Thalidomide and dexamethasone for newly diagnosed multiple myeloma: is this really the standard of care?J Clin Oncol. 2006 Jun 20;24(18):2967-8; author reply 2968-9. doi: 10.1200/JCO.2006.06.3115. J Clin Oncol. 2006. PMID: 16782938 No abstract available.
Comment on
-
Phase III clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma: a clinical trial coordinated by the Eastern Cooperative Oncology Group.J Clin Oncol. 2006 Jan 20;24(3):431-6. doi: 10.1200/JCO.2005.03.0221. Epub 2005 Dec 19. J Clin Oncol. 2006. PMID: 16365178 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
